Metastatic Prostate Cancer Clinical Trials in Houston, Texas

7 studies are recruiting for metastatic prostate cancer in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

    This study will determine whether the presence of DNA repair deficiency in the form of alterations in the genes ATM, CDK12 or CHEK2 predicts for a high likelihood of responding to the use of intermittent high dose testosterone. This therapy may result in responses in tumors which are genetically un…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas
    Locations
    17 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT05011383 on ClinicalTrials.gov

  2. Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

    Assessment of the safety and efficacy of HLD-0915 (JNJ-101556143) in patients with metastatic prostate cancer who have progressed on prior systemic therapies, with further evaluation in additional prostate cancer populations.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    MD Anderson Cancer Center, Houston, Texas
    Locations
    18 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT06800313 on ClinicalTrials.gov

  3. Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

    The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer agents for treatment of metastatic prostate cancer.

    Stage
    Phase 1
    Ages
    18 to 130
    Site
    Research Site, Houston, Texas
    Locations
    52 in total
    Run by
    AstraZeneca

    See if you can join NCT07181161 on ClinicalTrials.gov

  4. Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

    The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of multiple anti-cancer agents in participants with metastatic prostate cancer.

    Stage
    Phase 1
    Ages
    18 to 99
    Site
    Research Site, Houston, Texas
    Locations
    37 in total
    Run by
    AstraZeneca

    See if you can join NCT07590934 on ClinicalTrials.gov

  5. Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

    This is a prospective, open-label, multi-center seamless phase II to phase III randomized clinical trial designed to compare SST with or without PET-directed local therapy in improving the castration-resistant prostate cancer-free survival (CRPC-free survival) for Veterans with oligometastatic pros…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas
    Locations
    20 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT04787744 on ClinicalTrials.gov

  6. Study of AZD0754 in Participants With Metastatic Prostate Cancer

    The purpose of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate cancer.

    Stage
    Phase 1
    Ages
    18 to 130
    Site
    Research Site, Houston, Texas
    Locations
    15 in total
    Run by
    AstraZeneca

    See if you can join NCT06267729 on ClinicalTrials.gov

  7. A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab

    The purpose of this Phase 1/2 study is to test the overall safety, tolerability, and effectiveness of the combination investigational drugs evofosfamide, zalifrelimab, and balstilimab in treating advanced or metastatic castration-resistant prostate cancer, pancreatic cancer, and human papilloma vir…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    MD Anderson Cancer Center, Houston, Texas
    Run by
    ImmunoGenesis

    See if you can join NCT06782555 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.